Aperture Sectors › Healthcare & Life Sciences › Clinical documentation
Clinical documentation funding
Clinical documentation
A sub-sector of Healthcare & Life Sciences. Each company counts once, in its main sub-sector.
79 rounds, $2.8B raised by 56 companies, Jan 2, 2023 to Nov 14, 2026, 6% of Healthcare & Life Sciences capital. Top three companies: Abridge 38%, Ambience Healthcare 11%, Heidi 7%.
| Company | HQ | Capital raised | Rounds | Exit |
|---|---|---|---|---|
| Abridge | United States | $1B | 5 | — |
| Ambience Healthcare | United States | $313M | 2 | — |
| Heidi | Australia | $188M | 4 | — |
| Suki | United States | $160M | 3 | — |
| Tandem Health | Sweden | $160M | 3 | — |
| Rad AI | United States | $110M | 2 | — |
| Eleos | United States | $100M | 2 | — |
| Nabla | France | $94M | 2 | — |
| Eleos Health | United States | $60M | 2 | — |
| Corti | Denmark | $60M | 1 | — |
| voize | Germany | $59M | 2 | — |
| Telepatia | Brazil | $42M | 2 | — |
| Predoc | United States | $36M | 2 | — |
| Ritten | United States | $35M | 1 | — |
| Avelios Medical | Germany | $31M | 2 | — |
| Freed | United States | $30M | 1 | — |
| Pieces Technologies | United States | $25M | 1 | — |
| Smart Reporting | Germany | $24M | 1 | — |
| Tavrn | United States | $15M | 1 | — |
| Blueprint | United States | $15M | 1 | — |
| HealthEx | United States | $14M | 1 | — |
| Clara | United States | $12M | 1 | — |
| Barti | United States | $12M | 1 | — |
| Anima | United Kingdom | $12M | 1 | — |
| Dyania Health | United States | $10M | 1 | — |
| Company | Amount | Stage | Announced |
|---|---|---|---|
| Abridge | $316M | Series E | Jun 11, 2026 |
| Abridge | $300M | Series E | Jun 23, 2025 |
| Abridge | $250M | Series D | Feb 17, 2025 |
| Ambience Healthcare | $243M | Series C | Jul 29, 2025 |
| Abridge | $150M | Series C | Feb 23, 2024 |
| Heidi | $100M | Series C | Sep 22, 2026 |
| Tandem Health | $100M | Series B | Sep 14, 2026 |
| Suki | $90M | Series E | Oct 13, 2026 |
| Nabla | $70M | Series C | Jun 17, 2025 |
| Suki | $70M | Series D | Oct 10, 2024 |